PANACEA LIFE SCIENCES HOLDINGS, INC. Cash and Equivalents

Quick Answer

PANACEA LIFE SCIENCES HOLDINGS, INC. reported Cash and Equivalents of $100.9 thousand for fiscal year 2023.

PANACEA LIFE SCIENCES HOLDINGS, INC. Cash and Equivalents — Annual History

Fiscal Year Cash and Equivalents YoY Change
2023 $100.9K +1351.9%
2022 $7.0K -64.8%
2021 $19.8K -76.6%
2020 $84.4K +358.5%
2019 $18.4K +839.0%
2018 $2.0K -98.8%
2017 $161.2K -84.7%
2016 $1.06M
2015 $0.00 -100.0%
2014 $41.7K +17.4%
2013 $35.5K

Quarterly Cash and Equivalents

Quarter Ending Cash and Equivalents YoY QoQ
March 31, 2024 $107.6K +47.0% +6.7%
December 31, 2023 $100.9K +1351.9% +6650.6%
September 30, 2023 $1.5K -95.9% -81.7%
June 30, 2023 $8.2K -77.6% -88.8%
March 31, 2023 $73.2K +30.8% +953.5%
December 31, 2022 $7.0K -64.8% -81.1%
September 30, 2022 $36.8K +153.7% +0.7%
June 30, 2022 $36.5K -72.1% -34.8%
  • PANACEA LIFE SCIENCES HOLDINGS, INC. showed an increase of +1351.9% in Cash and Equivalents compared to the prior fiscal year.
  • Over the 2013–2023 period, PANACEA LIFE SCIENCES HOLDINGS, INC.’s cash and equivalents has grown by 184.3% (from $35.5 thousand to $100.9 thousand).
  • The most recent figure is from PANACEA LIFE SCIENCES HOLDINGS, INC.’s fiscal year 2023 report (Form 10-K), filed with the SEC on April 1, 2024.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment